Biora Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Biora Therapeutics has a total shareholder equity of $-101.4M and total debt of $46.1M, which brings its debt-to-equity ratio to -45.5%. Its total assets and total liabilities are $31.2M and $132.6M respectively.
Key information
-45.5%
Debt to equity ratio
US$46.11m
Debt
| Interest coverage ratio | n/a |
| Cash | US$15.21m |
| Equity | -US$101.42m |
| Total liabilities | US$132.64m |
| Total assets | US$31.22m |
Recent financial health updates
Recent updates
Biora Therapeutics granted patent for oral delivery of GLP-1 receptor agonists
Sep 13Biora Therapeutics: Checking In On The Transformation
Aug 17Biora rallies 30%, highest since November on data for drug delivery device
Aug 10Progenity: Analyzing The Huge Paradigm Shift
Dec 20Progenity: Transformation Raises Questions
Oct 03Progenity on a roller coaster ride since strategic transformation announcement
Jun 09Progenity presents new study data for preeclampsia rule-out Test
Apr 30Earnings Release: Here's Why Analysts Cut Their Progenity, Inc. (NASDAQ:PROG) Price Target To US$8.00
Mar 20
Financial Position Analysis
Short Term Liabilities: BIOR has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: BIOR has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOR has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: BIOR's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIOR has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BIOR is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.